Personalized immune medicine plan after intestinal transplant
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This Phase 1 study tests a way to lower (minimize) the immune-suppressing medicines after an intestinal transplant while still keeping the new organ safe. It uses blood tests that look at immune activity and “chimerism” to guide how strong the immune suppression needs to be.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently being evaluated for an intestinal or multi-visceral transplant at the study hospital, or on the national transplant list
- You are 18 to 65 years old and can sign consent yourself
- You can reliably return for follow-up visits at the study site for about 48 months
- You do not currently have serious infection or unstable sickness (like sepsis)
- You are not known to have an immune system disorder (immunodeficiency) and you don’t have advanced cancer that has spread (except certain neuro-endocrine cases)
- You can follow the study plan (including medications and visits), and you have dependable support at home
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a precise lab test can help understand inflammatory bowel disease, functional gut disorders, and immune changes after stem cell transplant or cell therapy. It may help doctors choose better monitoring and treatments based on your immune and gut test results.
This study tests a new approach to managing anti-rejection medicines after a heart transplant. It uses special blood tests to see if your immune system is calm, so doctors can safely reduce the medicines and lower side effects.
This trial tests whether taking probiotics made from your own and your donor's bacteria can help prevent or reduce gut problems (like diarrhea) after a stem cell transplant. It may help your intestines recover and feel better.
This early-phase study tests whether changing your gut bacteria with a fecal transplant can improve diarrhea or colitis caused by cancer immunotherapy. It may help people whose symptoms have not fully settled with standard treatments like steroids and other immune-blocking medicines.
This study tests whether transplanting healthy gut bacteria into people who have had part of their colon removed can improve recovery. It may help prevent infections or other complications after surgery.
This study tests whether a fecal transplant (transferring healthy donor bacteria into your gut) can help your immune system recover after a stem cell transplant. It may reduce the risk of infections while your immunity is still low.
Hear when a new Intestinal Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.